Clinical trial
Post-Authorisation Safety Study of Lesinurad
NCT04072471 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Authorisation Safety Study of Lesinurad
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- January 29, 2021
- Completion date
- June 30, 2023
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.